SEER Inquiry System - Home
Welcome to the SEER Inquiry System (SINQ). SINQ is a collection of questions that cancer registrars have had while coding cancer cases. Click Search to look for specific questions or to select questions for a Report.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Add to Report | ID | Question | Status | Last Updated | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 20091093 | Race--How and when is Appendix D – Race and Nationality Descriptions from the 2000 Census and Bureau of Vital Statistics to be used? Please see discussion. | Final | Aug 10 2009 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 20091090 | First course treatment--Leukemia: Should an allogeneic stem cell transplant for acute myeloid leukemia be coded to 20 in the Hematologic Transplant and Endocrine Procedures? There is debate as to whether this procedure should be coded as a 12 in order to capture the allogeneic part of the procedure. | Final | Aug 10 2009 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 20091089 | Histology--Hematopoietic: The final diagnosis on a bone marrow biopsy was "chronic lymphocytic leukemia with plasmacytic differentiation." Is this coded 9823/3, CLL/SLL or 9733/3, plasma cell leukemia? | Final | Aug 10 2009 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 20091085 | MP/H Rules/Histology--Breast: What is the correct histology code for this breast cancer case? Final diagnosis says, "Infiltrating duct carcinoma with apocrine features." What rule is used? See also discussion. | Final | Aug 10 2009 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 20091084 | Primary site--Colon: How do you determine the correct subsite when there is conflicting information in different reports? See discussion for case example. In this case, the Operative report seems more correct. Are there priority rules for this for sites other than Head and Neck? | Final | Aug 10 2009 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 20091083 | Grade/Cell indicator--Lymphoma: For pathology that states "anaplastic large cell lymphoma", is the grade code 4? The SPCM states cell indicator codes take precedence over grade/differentiation codes for lymphoma and leukemia cases. | Final | Aug 10 2009 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 20091082 | Behavior--Breast: What is the correct behavior code for these 2 scenarios? 1. Path report for breast cancer has final diagnosis as 'DCIS' but the CAP protocol in the body of the report says 'microinvasion seen, T1mic.' 2. Path report says 'DCIS' in the final diagnosis and microinvasion is identified in the microscopic portion of the report, but it is not in CAP protocol format and not stated in the final diagnosis. These are path reports from lab only cases (not otherwise reported to the central registry). |
Final | Aug 10 2009 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 20091081 | Reportability/Histology--Brain and CNS: Histology code 8825/1 (Inflammatory Myofibroblastic Tumor) is not listed in the ICD-0-3 Primary Brain and CNS Site/Histology listing for reportable Brain/CNS tumors. It seems this might be a reportable tumor? | Final | Aug 10 2009 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 20091079 | Primary site--Bladder: What is the correct subsite for interureteric ridge? Description: 4 mm nodule at base of bladder near interureteric ridge. | Final | Aug 10 2009 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 20091072 | Histology--Brain and CNS: What histology code is used for a rosette-forming glioneuronal tumor of the fourth ventricle? | Final | Aug 10 2009 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
